Cellosaurus NK-92 (CVCL_2142)

Cell line name NK-92
Synonyms NK92
Accession CVCL_2142
Resource Identification Initiative To cite this cell line use: NK-92 (RRID:CVCL_2142)
Comments Characteristics: IL2 dependent.
Characteristics: Does not express FCGR3A/CD16.
Doubling time: ~40-50 hours (DSMZ).
Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
Omics: Transcriptome analysis.
Disease Natural killer cell lymphoblastic leukemia/lymphoma (NCIt: C82217)
Species of origin Homo sapiens (Human) (NCBI Taxonomy: 9606)
Hierarchy Children: CVCL_W733 (GFP-CD16-F/F.NK-92); CVCL_W734 (GFP-CD16-V/V.NK-92); CVCL_IM23 (haNK); CVCL_U271 (NK-92CI); CVCL_3755 (NK-92MI); CVCL_V429 (NoGFP-CD16.NK92)
Sex of cell Male
Category Cancer cell line
STR profile Source(s): ATCC; DSMZ

Markers:
AmelogeninX,Y
CSF1PO11,12
D13S3179,12
D16S53911,12
D5S81812,13
D7S82010,11
TH016,9.3
TPOX8
vWA18 (ATCC)
16,18 (DSMZ)
Web pages https://en.wikipedia.org/wiki/NK-92
http://www2.kumc.edu/soalab/LabLinks/cell%20lines/nk92.htm
Publications

PubMed=8152260
Gong J.-H., Maki G., Klingemann H.-G.
Characterization of a human cell line (NK-92) with phenotypical and functional characteristics of activated natural killer cells.
Leukemia 8:652-658(1994)

PubMed=9118301
Klingemann H.-G., Wong E., Maki G.
A cytotoxic NK-cell line (NK-92) for ex vivo purging of leukemia from blood.
Biol. Blood Marrow Transplant. 2:68-75(1996)

PubMed=10803505; DOI=10.1038/sj.leu.2401778
Drexler H.G., Matsuo Y.
Malignant hematopoietic cell lines: in vitro models for the study of natural killer cell leukemia-lymphoma.
Leukemia 14:777-782(2000)

PubMed=11454312; DOI=10.1089/152581601750288975
Maki G., Klingemann H.-G., Martinson J.A., Tam Y.K.
Factors regulating the cytotoxic activity of the human natural killer cell line, NK-92.
J. Hematother. Stem Cell Res. 10:369-383(2001)

PubMed=19194464; DOI=10.1038/leu.2009.3
Iqbal J., Kucuk C., Deleeuw R.J., Srivastava G., Tam W., Geng H., Klinkebiel D., Christman J.K., Patel K., Cao K., Shen L., Dybkaer K., Tsui I.F.L., Ali H., Shimizu N., Au W.Y., Lam W.L., Chan W.C.
Genomic analyses reveal global functional alterations that promote tumor growth and novel tumor suppressor genes in natural killer-cell malignancies.
Leukemia 23:1139-1151(2009)

PubMed=20454443; DOI=10.1155/2010/904767
Uphoff C.C., Denkmann S.A., Steube K.G., Drexler H.G.
Detection of EBV, HBV, HCV, HIV-1, HTLV-I and -II, and SMRV in human and other primate cell lines.
J. Biomed. Biotechnol. 2010:904767-904767(2010)

PubMed=21052088; DOI=10.1038/leu.2010.255
Iqbal J., Weisenburger D.D., Chowdhury A., Tsai M.Y., Srivastava G., Greiner T.C., Kucuk C., Deffenbacher K., Vose J., Smith L., Au W.Y., Nakamura S., Seto M., Delabie J., Berger F., Loong F., Ko Y.-H., Sng I., Liu X., Loughran T.P., Armitage J.O., Chan W.C.
Natural killer cell lymphoma shares strikingly similar molecular features with a group of non-hepatosplenic gammadelta T-cell lymphoma and is highly sensitive to a novel aurora kinase A inhibitor in vitro.
Leukemia 25:348-358(2011)

PubMed=25586472; DOI=10.1038/ncomms7025
Kucuk C., Jiang B., Hu X., Zhang W., Chan J.K.C., Xiao W., Lack N., Alkan C., Williams J.C., Avery K.N., Kavak P., Scuto A., Sen E., Gaulard P., Staudt L.M., Iqbal J., Zhang W., Cornish A., Gong Q., Yang Q., Sun H., d'Amore F., Leppa S., Liu W., Fu K., de Leval L., McKeithan T., Chan W.C.
Activating mutations of STAT5B and STAT3 in lymphomas derived from gammadelta-T or NK cells.
Nat. Commun. 6:6025-6025(2015)

Cross-references
Cell line collections AddexBio; C0003026/NA - Discontinued
ATCC; CRL-2407
ATCC; PTA-6670 - Discontinued
BCRC; 60414
DSMZ; ACC-488
Cell line databases/resources CCRID; 3131C0001000200020
Ontologies BTO; BTO:0003287
CLO; CLO_0008177
Biological sample resources BioSample; SAMN03471836
Gene expression databases GEO; GSM472001
Other Wikidata; Q17149636
Polymorphism and mutation databases Cosmic; 1534874
Cosmic; 1542071
Cosmic; 2025326
Cosmic; 2390215